NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapies aim to shrink head and neck tumors
Disease control OngoingThis study tests whether combining different immunotherapy drugs can shrink tumors better than one drug alone in people with a type of head and neck cancer that has come back or spread. It includes 316 adults whose cancer has a specific marker (PD-L1 positive) and who have not ha…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 04:45 UTC
-
New combo therapy aims to boost immune attack against HPV-driven head and neck cancer
Disease control OngoingThis phase 3 study tests whether adding an experimental immunotherapy (PDS0101) to standard pembrolizumab helps people with advanced HPV16-positive head and neck cancer live longer or delay cancer growth. About 252 participants will receive either the combination or pembrolizumab…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC